LAUSR

Covid-19 is a global health threat as it spreads widely and rapidly. This pandemic was first detected at the end of December in Wuhan city of China [1]. The first case in Syria was reported on 22 March 2020 [2]. Syria’s Healthcare Capacity to respond to a COVID-19 Outbreak was rapid but not sufficient as the Syrian war made a bad impact on Syria’s Healthcare to face another crisis. The Syrian Ministry of Health Committed the World Health Organization (WHO) Covid-19 management guidelines but a necessity to reduce prevalence and death rate suppose the need of a safe and effective vaccine [3]. Multiple available vaccines had been developed, but the big challenge was when vaccine hesitancy appeared [3]. Syria’s Healthcare faces vaccines hesitancy challenges in the different sites from Syria, especially rural areas [3]. Many causes influenced the acceptance of the vaccines including fear of side effects, doubts about vaccine efficiency, the vaccine is not important, and not the right time to be vaccinated, ongoing conflict, huge displacement, inflated economy and the fragile, fragmented health system, also lack of actual learning of threats of COVID-19 and the proven benefits of COVID-19 vaccine [3]. Vaccine hesitancy is the term used to define refusal or reluctance in the acceptance of vaccination despite the availability of vaccination services. The modern endorsement of vaccine hesitancy is a well-known phenomenon, with older roots that have accompanied vaccination since its scientific inception [3]. Regarding Syria with COVID-19 vaccine, many obstacles arise toward vaccination, which include Vaccine hesitancy, but also the shortage of vaccine doses offered to population in need and distribution of vaccine which limited in some governments and affected by the poor economic situation is Syria [3]. According to the WHO Syria Situation Report for June 2021, Syria